Trial Profile
Phase II Study of Primary Chemotherapy with Anthracycline-based Regimen Followed by Nab-paclitaxel and Trastuzumab in Patients with HER2 Positive Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Cyclophosphamide; Doxorubicin; Epirubicin; Fluorouracil; Trastuzumab
- Indications Early breast cancer; HER2 positive breast cancer
- Focus Therapeutic Use
- 21 Apr 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 29 Jan 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 09 Sep 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01432223).